HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kyeongmee Park Selected Research

Vascular Endothelial Growth Factor Receptor-3 (Flt 4)

2/2013The prognostic significance of growth factors and growth factor receptors in gastric adenocarcinoma.
7/2011Prognostic significance of epidermal growth factor receptor and vascular endothelial growth factor receptor in colorectal adenocarcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kyeongmee Park Research Topics

Disease

17Neoplasms (Cancer)
06/2017 - 06/2002
16Breast Neoplasms (Breast Cancer)
06/2017 - 06/2002
6Adenocarcinoma
09/2017 - 05/2005
6Carcinoma (Carcinomatosis)
01/2016 - 11/2003
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2012 - 11/2003
2Carcinogenesis
09/2017 - 03/2009
2Neoplasm Metastasis (Metastasis)
03/2009 - 01/2003
2Uterine Cervical Dysplasia
07/2007 - 05/2005
2Uterine Cervical Neoplasms (Cancer of the Cervix)
07/2007 - 05/2005
2Colorectal Neoplasms (Colorectal Cancer)
01/2006 - 03/2004
1Epstein-Barr Virus Infections
09/2017
1Lymphatic Metastasis
07/2017
1Triple Negative Breast Neoplasms
09/2016
1Noninfiltrating Intraductal Carcinoma (DCIS)
06/2016
1Margins of Excision
06/2016
1Pleural Effusion (Pleural Effusions)
04/2013
1Metaplasia
02/2013
1Gastritis
02/2013
1Histiocytic Necrotizing Lymphadenitis (Kikuchi Disease)
09/2012
1Adenolymphoma
09/2011
1Prostatic Neoplasms (Prostate Cancer)
06/2008
1Tonsillitis
04/2007
1Adenocarcinoma of Lung
01/2006
1Adenoid Cystic Carcinoma (Cylindroma)
05/2005
1Rupture
04/2003

Drug/Important Bio-Agent (IBA)

5Proteins (Proteins, Gene)FDA Link
09/2017 - 06/2002
4ErbB Receptors (EGF Receptor)IBA
02/2013 - 11/2003
4Cyclophosphamide (Cytoxan)FDA LinkGeneric
09/2011 - 06/2002
3Hormones (Hormone)IBA
07/2017 - 06/2008
3Progesterone Receptors (Progesterone Receptor)IBA
07/2017 - 06/2016
3SilverIBA
06/2017 - 12/2011
3Estrogen ReceptorsIBA
09/2016 - 01/2003
3Fluorouracil (Carac)FDA LinkGeneric
09/2011 - 08/2003
3Doxorubicin (Adriamycin)FDA LinkGeneric
08/2006 - 06/2002
2human ERBB2 proteinIBA
07/2017 - 06/2016
2Trastuzumab (Herceptin)FDA Link
05/2013 - 06/2002
2MucinsIBA
04/2013 - 04/2003
2Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
02/2013 - 07/2011
2Vascular Endothelial Growth Factor DIBA
02/2013 - 07/2011
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2013 - 07/2011
2Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA
02/2013 - 07/2011
2Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
02/2013 - 07/2011
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
02/2013 - 07/2011
2Transforming Growth Factors (Transforming Growth Factor)IBA
02/2013 - 07/2011
2Methotrexate (Mexate)FDA LinkGeneric
09/2011 - 08/2003
2Cyclooxygenase 2 (Cyclooxygenase-2)IBA
05/2005 - 03/2004
2Cyclin D1IBA
08/2003 - 01/2003
1Interleukin-17 (Interleukin 17)IBA
09/2017
1CytokinesIBA
09/2017
1Interleukin-6 (Interleukin 6)IBA
09/2017
1Epidermal Growth Factor (EGF)IBA
09/2016
1Phenobarbital (Luminal)FDA Link
09/2016
1Estrogens (Estrogen)FDA Link
09/2016
1Keratin-20 (Cytokeratin 20)IBA
01/2016
1Formaldehyde (Formol)FDA Link
05/2013
1ParaffinIBA
05/2013
1Growth Factor ReceptorsIBA
02/2013
1Keratins (Keratin)IBA
10/2012
1DesminIBA
10/2012
1S100 Proteins (S 100 Protein)IBA
10/2012
1VimentinIBA
10/2012
1MyogeninIBA
10/2012
1Granzymes (Granzyme)IBA
09/2012
1AntibodiesIBA
04/2012
1Carcinoembryonic AntigenIBA
01/2012
1DNA (Deoxyribonucleic Acid)IBA
09/2011
1Vinorelbine (Navelbine)FDA LinkGeneric
09/2011
1Insulin (Novolin)FDA Link
07/2011
1taxaneIBA
07/2010
1Docetaxel (Taxotere)FDA Link
06/2009
1Epirubicin (Ellence)FDA LinkGeneric
06/2009
1OsteopontinIBA
03/2009
1Messenger RNA (mRNA)IBA
03/2009
1NF-kappa B (NF-kB)IBA
03/2009
1S-Phase Kinase-Associated Proteins (Skp1 Protein)IBA
07/2007
1Cyclin AIBA
04/2007
1Cyclin B1IBA
04/2007
1SurvivinIBA
04/2007
1Type II DNA Topoisomerases (Topoisomerase II)IBA
08/2006
1Melanins (Melanin)IBA
06/2006
1Inhibins (Inhibin)IBA
05/2006
1activin AIBA
05/2006
1Phosphotransferases (Kinase)IBA
01/2006
1Monoclonal AntibodiesIBA
05/2005
1ErbB-2 ReceptorIBA
05/2005
1Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
03/2004
1Retinoblastoma ProteinIBA
11/2003
1Cyclin EIBA
08/2003
1TamoxifenFDA LinkGeneric
01/2003
1CyclinsIBA
01/2003
1Paclitaxel (Taxol)FDA LinkGeneric
06/2002
1B 31IBA
06/2002

Therapy/Procedure

7Drug Therapy (Chemotherapy)
05/2013 - 08/2003
3Therapeutics
09/2016 - 01/2003
3Radiotherapy
06/2016 - 11/2003
3Segmental Mastectomy (Lumpectomy)
06/2016 - 01/2007
3Adjuvant Chemotherapy
09/2011 - 08/2006
2Neoadjuvant Therapy
07/2010 - 06/2009
1Nephroureterectomy
01/2016
1Brachytherapy
06/2010